There are 2789 resources available
1665TiP - High-dose vs standard-dose thoracic radiotherapy for extensive stage small cell lung cancer: Study protocol for a phase III randomized trial
Presenter: Yufan Yang
Session: ePoster Display
1637P - Unintended consequences for an integrated oncology ecosystem from COVID adaptations
Presenter: Philip Bredin
Session: ePoster Display
1638P - Experience with telemedicine during COVID-19 pandemic
Presenter: Sandra Soriano
Session: ePoster Display
1555TiP - A phase II single-arm study of pembrolizumab plus lenvatinib in previously treated classic Kaposi sarcoma (CKS): The PULSAR trial
Presenter: Alice Indini
Session: ePoster Display
1568P - Clinical and laboratory outcomes of solid cancer patients reinfected with SARS-CoV-2
Presenter: Ozan Yazıcı
Session: ePoster Display
1569P - A multicenter analysis of the outcome of cancer patients with neutropenia and COVID-19 infection optionally treated with granulocyte colony-stimulating factor (G-CSF): A comparative analysis
Presenter: Maria Sereno Moyano
Session: ePoster Display
1570P - Outcome and prognostic factors of COVID-19 infection in cancer patients: Final results of SAKK 80/20
Presenter: Markus Joerger
Session: ePoster Display
1571P - COVID-19 positivity rates in patients with an active cancer diagnosis in the University of California Cancer Consortium
Presenter: Julian Hong
Session: ePoster Display
1572P - The impact of COVID-19 pandemic on Spanish genitourinary (GU) cancer patients: SOGUG-COVID-19 study
Presenter: Miguel Angel Climent Duran
Session: ePoster Display